Analisis Keuangan Saham ASPHF - Ascentage Pharma Group International (OTCPK) Stock

Gambaran Umum

Ascentage Pharma Group International, based in China, is a biopharmaceutical company focused on developing innovative small molecule therapies. It primarily operates in the oncology sector, with a notable emphasis on apoptosis-targeted drug development. The company has a robust pipeline featuring several key projects, most notably its series of novel Bcl-2 inhibitors designed to prompt cancer cell death, and IAP inhibitors that suppress cancer growth pathways. Additionally, Ascentage Pharma is actively advancing drug candidates targeting the protein-protein interaction and the tyrosine kinase receptor pathways. These pioneering projects underscore the company's strategic commitment to addressing unmet medical needs in the treatment of cancers and other serious diseases.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai revenue untuk Ascentage Pharma Group International per 2025 Jun 30 adalah 390.60 MM.
Nilai operating income untuk Ascentage Pharma Group International per 2025 Jun 30 adalah -1,120.77 MM.
Nilai net income untuk Ascentage Pharma Group International per 2025 Jun 30 adalah -1,159.20 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	390.60	-1,120.77	-1,159.20
2025-03-31	685.63	-749.79	-782.32
2024-12-31	980.65	-378.80	-405.43
2024-09-30	941.84	-361.44	-382.86
2024-06-30	903.03	-344.08	-360.29
2024-03-31	562.51	-618.04	-642.96
2023-12-31	221.98	-891.99	-925.64
2023-09-30	239.32	-865.49	-902.09
2023-06-30	256.65	-838.98	-878.54
2023-03-31	233.18	-861.19	-880.73
2022-12-31	209.71	-883.41	-882.92
2022-09-30	160.21	-919.62	-847.70
2022-06-30	110.71	-955.84	-812.48
2022-03-31	69.31	-944.50	-797.45
2021-12-31	27.91	-933.17	-782.42
2021-09-30	25.36	-844.37	-758.77
2021-06-30	22.80	-755.58	-735.11
2021-03-31	17.63	-720.00	-706.36
2020-12-31	12.45	-684.43	-677.61
2020-09-30	13.63	-674.81	-922.09
2020-06-30
2020-03-31

Laporan Laba Rugi: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30	-1.24	-1.23
2024-03-31	-2.24	-2.24
2023-12-31	-3.28
2023-09-30	-3.27	-3.27
2023-06-30	-3.26	-3.27
2023-03-31	-3.31	-3.31
2022-12-31	-3.35
2022-09-30	-3.22	-3.22
2022-06-30	-3.09	-3.09
2022-03-31	-3.08	-3.08
2021-12-31	-3.07
2021-09-30	-3.10	-3.10
2021-06-30	-3.13	-3.13
2021-03-31	-3.13	-3.13
2020-12-31	-3.14
2020-09-30	-4.75	-4.75
2020-06-30	-6.76	-6.76
2020-03-31	-9.15	-9.15

Arus Kas: Operasi, Investasi, Pendanaan

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30
2025-03-31
2024-12-31	-111.36	-362.04	314.77
2024-09-30	-411.68	-203.31	312.39
2024-06-30	-712.00	-44.58	310.02
2024-03-31	-719.04	-11.33	339.39
2023-12-31	-726.08	21.92	368.75
2023-09-30	-706.63	-142.43	497.95
2023-06-30	-687.18	-306.79	627.14
2023-03-31	-670.55	-345.70	623.21
2022-12-31	-653.91	-384.61	619.27
2022-09-30	-620.11	5.37	886.00
2022-06-30	-586.30	395.35	1,152.74
2022-03-31	-595.49	-35.59	1,467.06
2021-12-31	-604.68	-466.52	1,781.39
2021-09-30	-634.80	-685.70	1,852.21
2021-06-30	-664.91	-904.89	1,923.03
2021-03-31	-637.43	-506.13	1,481.52
2020-12-31	-609.96	-107.37	1,040.00
2020-09-30	-575.85	-239.17	809.34
2020-06-30
2020-03-31

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Efektivitas Manajemen

roa untuk Ascentage Pharma Group International pada 2025 Jun 30 adalah -0.13.
roe untuk Ascentage Pharma Group International pada 2025 Jun 30 adalah -0.52.
roic untuk Ascentage Pharma Group International pada 2025 Jun 30 adalah -0.21.
croic untuk Ascentage Pharma Group International pada 2025 Jun 30 adalah -0.07.
ocroic untuk Ascentage Pharma Group International pada 2025 Jun 30 adalah -0.06.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2025-06-30	-0.13	-0.52	-0.21	-0.07	-0.06
2025-03-31	-0.13	-0.52	-0.21	0.00	0.00
2024-12-31	-0.14	-5.10	-0.15	-0.18	-0.29
2024-09-30	-0.14	-5.10	-0.15	-0.12	-0.29
2024-06-30		-1.07
2024-03-31		-2.27
2023-12-31			-9.67	-3.26
2023-09-30			-1.41	-0.48
2023-06-30		-1.00
2023-03-31		-1.00
2022-12-31
2022-09-30		0.00
2022-06-30		-0.56	-0.90
2022-03-31		0.00
2021-12-31		0.00
2021-09-30	0.00	0.00
2021-06-30	-0.66		-0.34	0.14	-0.31
2021-03-31	-0.64	-1.15	-0.33	0.14	-0.30
2020-12-31	-0.56	-0.76	-0.48	0.20	-0.43
2020-09-30	-0.77	-1.04	-0.65	-0.02	-0.41
2020-06-30	-1.09		-1.30	-0.37	-0.60
2020-03-31	-1.23		-1.47	-0.31	-0.56

Gross Margins

marjin kotor untuk Ascentage Pharma Group International pada 2025 Jun 30 adalah 0.97.
marjin bersih untuk Ascentage Pharma Group International pada 2025 Jun 30 adalah -0.41.
marjin operasi untuk Ascentage Pharma Group International pada 2025 Jun 30 adalah -0.39.

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2025-06-30	0.97	-0.41	-0.39
2025-03-31	0.97	-0.41	-0.39
2024-12-31	0.97	-0.40	-0.38
2024-09-30	0.97	-0.40	-0.38
2024-06-30
2024-03-31
2023-12-31
2023-09-30		-3.42	-3.27
2023-06-30		-3.42	-3.27
2023-03-31		-3.78	-3.69
2022-12-31
2022-09-30
2022-06-30		-7.34	0.00
2022-03-31
2021-12-31
2021-09-30
2021-06-30	0.80	-32.24	-33.14
2021-03-31	0.82	-40.07	-40.85
2020-12-31	0.84	-54.43	-54.97
2020-09-30	0.85	-67.65	-49.51
2020-06-30	0.86	-78.77	-44.92
2020-03-31	0.86	-90.28	-43.60

HK:6855	HK$ 79.35
DE:36X	€ 8.65